How AI uncovers new ways to tackle difficult diseases

Published On Jan 9, 2025, 7:17 PM

Insilico Medicine, an AI-driven biotech firm, is using artificial intelligence in drug discovery to develop new treatments, including for idiopathic pulmonary fibrosis (IPF). They have successfully identified new molecules faster than traditional methods, significantly reducing the time and cost involved in the drug development process. The growing trend of employing AI in pharmaceuticals signifies a shift towards more efficient drug discovery, with several companies, including Alphabet's Isomorphic Labs and Recursion Pharmaceuticals, also exploring this technology. Insilico has multiple drugs in clinical trials, and there is optimism that AI can improve the success rate of bringing drugs to market.